Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06071858 · ClinicalTrials.gov registry record · NA
Enhanced Coordinated Specialty Care for Early Psychosis
A NA study of Schizophrenia and Bipolar Disorder, sponsored by Mclean Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 5
- Study locations
NCT06071858: Recruiting NA study of Schizophrenia and Bipolar Disorder, sponsored by Mclean Hospital.
NCT06071858 is a NA study of Schizophrenia and Bipolar Disorder that is actively recruiting participants, run by Mclean Hospital. The registered enrollment target is 350 participants, above the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (61% higher). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06071858, a NA study of Schizophrenia and Bipolar Disorder, is actively recruiting participants, sponsored by Mclean Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 5
- Study locations
Study Summary
The goal of this clinical trial is to compare engagement in treatment in coordinated specialty care (CSC) to five extra care elements (CSC 2.0) in first-episode psychosis. The main question it aims to answer is: • Does the addition of certain elements of care increase the number of visits in treatment for first-episode psychosis? Participants will either: * Receive care as usual (CSC) or * Receive care as usual (CSC) plus five additional care elements (CSC 2.0): 1. Individual peer support 2. Digital outreach 3. Care coordination 4. Multi-family group therapy 5. Cognitive remediation Researchers will compare the standard of care (CSC) to CSC 2.0 to see if participants receiving CSC 2.0 have more visits to their clinic in their first year.
Primary Outcome
Number of months each participant had ≥4 visits in a 12-month period
Conditions Studied
Interventions
- BEHAVIORAL Care Coordination
- BEHAVIORAL Individual Peer Support
- BEHAVIORAL Digital Outreach
- BEHAVIORAL Cognitive Remediation
- BEHAVIORAL Multi-Family Group Therapy
Study Locations (5)
Massachusetts
- McLean Hospital OnTrack Clinic - Belmont
- Massachusetts General Hospital FEPP Clinic - Boston
- Boston Medical Center WRAP - Boston
- Cambridge Health Alliance RISE Clinic - Cambridge
- UMass Memorial Community Healthlink STEP Clinic - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2028-10 |
| Phase | NA |
What NCT06071858 shows while recruiting
NCT06071858 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, above the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (61% higher).
The record links to 5 conditions, with Schizophrenia appearing as the primary indexed condition, and to 5 interventions - of which Care Coordination is the first listed.
NCT06071858 lists 5 locations in 1 state (Massachusetts).
Frequently Asked Questions
What is clinical trial NCT06071858 about?
NCT06071858 is a clinical study titled "Enhanced Coordinated Specialty Care for Early Psychosis". The goal of this clinical trial is to compare engagement in treatment in coordinated specialty care (CSC) to five extra care elements (CSC 2.0) in first-episode psychosis. The main question it aims to answer is: • Does the addition of certain elements of care increase the number of visits in treatm...
What is the current status of trial NCT06071858?
This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2024-02-01. Estimated completion is 2028-10.
What conditions does trial NCT06071858 study?
This clinical trial studies the following conditions: Schizophrenia, Bipolar Disorder, Schizoaffective Disorder, Psychosis, Psychosis Nos/Other.
What interventions are being tested in trial NCT06071858?
The interventions under investigation include: Care Coordination (BEHAVIORAL), Individual Peer Support (BEHAVIORAL), Digital Outreach (BEHAVIORAL), Cognitive Remediation (BEHAVIORAL), Multi-Family Group Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06071858?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06071858 being conducted?
This trial has 5 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06071858's enrollment target sits among peer trials
350 49th of 315 higher than 267 of 315 other Schizophrenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
TMS for Inhibition Enhancement in Schizophrenia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI